Serplulimab Combined With CCRT for LS-SCLC.

Conditions: Small Cell Lung Cancer Interventions: Drug: Serplulimab Sponsors: Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials